SCHEMBL5314459

SCHEMBL5314459

Nc1ccccc1C(=O)N1CCCN(c2ccc(C(=O)NCCC3CC3)cn2)C1=O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGLN1 Q9GZT9 5/20 0.45
ALDH1A1 P00352 3/20 0.41
RAB9A P51151 3/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
NPC1 O15118 2/20 0.41
MAPT P10636 2/20 0.41
LMNA P02545 1/20 0.41
TSHR P16473 1/20 0.41
KDM4E B2RXH2 2/20 0.41
TP53 P04637 1/20 0.41
HPGD P15428 1/20 0.41
HTT P42858 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
SCD O00767 3/20 0.40
MAPK1 P28482 1/20 0.38
KIT P10721 2/20 0.38
MAPK14 Q16539 2/20 0.38
LCK P06239 1/20 0.38
SRC P12931 1/20 0.38
HDAC1 Q13547 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5309115 0.89 SCD (0.53) EGLN1ALDH1A1RAB9ASMN1; SMN2NPC1
SCHEMBL5309728 0.85 ALDH1A1 (0.41) EGLN1ALDH1A1RAB9ASMN1; SMN2NPC1
SCHEMBL5312604 0.85 SCD (0.41) EGLN1ALDH1A1RAB9ASMN1; SMN2NPC1
SCHEMBL5309059 0.84 SCD (0.53) ALDH1A1RAB9ASMN1; SMN2NPC1MAPT
SCHEMBL5314462 0.83 EGLN1 (0.44) EGLN1ALDH1A1RAB9ASMN1; SMN2NPC1
SCHEMBL5307182 0.83 SCD (0.54) ALDH1A1RAB9ASMN1; SMN2NPC1MAPT
SCHEMBL5312488 0.82 SCD (0.47) EGLN1ALDH1A1RAB9ASMN1; SMN2NPC1
SCHEMBL5315075 0.81 SCD (0.50) EGLN1ALDH1A1SMN1; SMN2HPGDSCD
SCHEMBL5307475 0.79 CA2 (0.41) EGLN1ALDH1A1RAB9ASMN1; SMN2KDM4E
SCHEMBL5306119 0.79 EGLN1 (0.42) EGLN1ALDH1A1SMN1; SMN2HPGDHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007046867-A2 PIPERIDINE DERIVATIVES AND THEIR USES AS THERAPEUTIC AGENTS XENON PHARMACEUTICALS INC. (CA) 2007-04-26 WO disclosed